| 8.1 |
56.9 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 6.9 |
27.5 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 6.4 |
19.1 |
GO:0030421 |
defecation(GO:0030421) |
| 5.7 |
22.6 |
GO:0003360 |
brainstem development(GO:0003360) |
| 5.0 |
14.9 |
GO:0060489 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 4.9 |
14.6 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 4.5 |
22.5 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 4.4 |
13.2 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 4.3 |
4.3 |
GO:0048546 |
digestive tract morphogenesis(GO:0048546) |
| 3.8 |
3.8 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 3.7 |
11.1 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 3.7 |
14.6 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 3.5 |
10.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 3.5 |
3.5 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 3.5 |
10.4 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 3.3 |
3.3 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 3.2 |
19.4 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 3.2 |
12.9 |
GO:1902724 |
positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 3.2 |
9.6 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 3.2 |
25.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 3.1 |
9.3 |
GO:0072382 |
minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 3.0 |
6.0 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 2.9 |
2.9 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 2.9 |
8.6 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 2.8 |
11.0 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 2.7 |
8.2 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 2.7 |
8.2 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 2.7 |
8.0 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 2.6 |
7.8 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 2.6 |
7.7 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 2.5 |
7.6 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 2.5 |
10.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 2.5 |
7.5 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 2.5 |
12.5 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 2.5 |
12.3 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 2.5 |
12.3 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 2.4 |
36.7 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 2.4 |
7.2 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 2.4 |
2.4 |
GO:0048818 |
positive regulation of hair follicle maturation(GO:0048818) |
| 2.4 |
7.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 2.4 |
9.5 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 2.4 |
7.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 2.3 |
7.0 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 2.3 |
2.3 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 2.3 |
6.9 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 2.3 |
11.5 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 2.3 |
4.6 |
GO:0002248 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
| 2.2 |
6.6 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 2.2 |
6.5 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 2.2 |
6.5 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 2.2 |
19.6 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 2.2 |
6.5 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 2.2 |
10.8 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 2.2 |
10.8 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 2.1 |
6.4 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 2.1 |
20.9 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 2.0 |
8.2 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 2.0 |
8.1 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 2.0 |
20.3 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 1.9 |
11.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.9 |
1.9 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 1.9 |
3.9 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 1.9 |
5.7 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.9 |
9.5 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 1.9 |
7.6 |
GO:0061743 |
motor learning(GO:0061743) |
| 1.9 |
22.4 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 1.9 |
14.9 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.8 |
38.8 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 1.8 |
7.3 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.8 |
1.8 |
GO:0000050 |
urea cycle(GO:0000050) arginine biosynthetic process(GO:0006526) urea metabolic process(GO:0019627) |
| 1.8 |
14.3 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 1.8 |
1.8 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 1.8 |
12.4 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 1.8 |
8.8 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 1.7 |
1.7 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 1.7 |
5.2 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 1.7 |
10.4 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 1.7 |
5.2 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 1.7 |
5.1 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 1.7 |
11.9 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 1.7 |
8.5 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 1.7 |
3.4 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 1.7 |
21.7 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 1.7 |
3.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.7 |
6.6 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 1.7 |
6.6 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.6 |
1.6 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 1.6 |
3.3 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 1.6 |
14.7 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 1.6 |
4.9 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 1.6 |
13.0 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 1.6 |
6.5 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 1.6 |
4.8 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 1.6 |
1.6 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.6 |
4.8 |
GO:0014028 |
notochord formation(GO:0014028) |
| 1.6 |
4.8 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 1.6 |
9.4 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 1.6 |
4.7 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 1.6 |
6.2 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.5 |
4.6 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 1.5 |
1.5 |
GO:0072309 |
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
| 1.5 |
4.5 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 1.5 |
4.4 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 1.5 |
4.4 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.5 |
4.4 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 1.5 |
4.4 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
| 1.5 |
1.5 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 1.5 |
13.2 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 1.5 |
1.5 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 1.4 |
11.5 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 1.4 |
2.9 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 1.4 |
4.2 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.4 |
5.6 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.4 |
1.4 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 1.4 |
2.8 |
GO:0009814 |
defense response, incompatible interaction(GO:0009814) |
| 1.4 |
4.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 1.4 |
5.6 |
GO:0043587 |
tongue morphogenesis(GO:0043587) fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
| 1.4 |
1.4 |
GO:0007135 |
meiosis II(GO:0007135) |
| 1.4 |
8.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 1.4 |
2.8 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 1.4 |
6.8 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 1.4 |
4.1 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 1.4 |
9.5 |
GO:0072615 |
interleukin-17 secretion(GO:0072615) |
| 1.4 |
13.5 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 1.4 |
5.4 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 1.3 |
5.4 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 1.3 |
5.4 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 1.3 |
12.0 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 1.3 |
6.6 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 1.3 |
5.3 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 1.3 |
5.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 1.3 |
1.3 |
GO:2000027 |
regulation of organ morphogenesis(GO:2000027) |
| 1.3 |
2.6 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 1.3 |
6.5 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.3 |
1.3 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 1.3 |
7.7 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 1.3 |
1.3 |
GO:0032911 |
transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 1.3 |
3.9 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 1.3 |
5.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.3 |
2.6 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 1.3 |
15.2 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 1.3 |
6.3 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 1.3 |
10.1 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 1.3 |
5.0 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 1.3 |
15.1 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 1.3 |
6.3 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 1.3 |
8.8 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 1.3 |
8.8 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 1.2 |
8.7 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 1.2 |
5.0 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 1.2 |
11.2 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 1.2 |
16.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 1.2 |
3.7 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 1.2 |
1.2 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 1.2 |
6.2 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 1.2 |
4.9 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 1.2 |
11.0 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 1.2 |
3.7 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 1.2 |
2.4 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 1.2 |
12.2 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 1.2 |
3.6 |
GO:0090269 |
fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.2 |
10.8 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 1.2 |
9.6 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 1.2 |
3.6 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 1.2 |
4.8 |
GO:0030091 |
protein repair(GO:0030091) |
| 1.2 |
3.6 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.2 |
2.3 |
GO:0014891 |
striated muscle atrophy(GO:0014891) |
| 1.2 |
4.7 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 1.2 |
11.7 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 1.2 |
4.7 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.2 |
6.9 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.2 |
9.2 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 1.1 |
4.6 |
GO:1902340 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 1.1 |
3.4 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.1 |
1.1 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 1.1 |
3.4 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 1.1 |
1.1 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.1 |
5.7 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 1.1 |
7.9 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 1.1 |
4.5 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 1.1 |
6.8 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 1.1 |
3.4 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 1.1 |
1.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 1.1 |
4.5 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 1.1 |
3.4 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 1.1 |
4.5 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 1.1 |
6.7 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 1.1 |
6.7 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 1.1 |
1.1 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.1 |
4.4 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 1.1 |
1.1 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 1.1 |
3.3 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 1.1 |
3.3 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 1.1 |
2.2 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 1.1 |
4.3 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 1.1 |
7.6 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 1.1 |
3.2 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 1.1 |
10.8 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 1.1 |
18.1 |
GO:0042772 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 1.1 |
3.2 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 1.1 |
27.4 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 1.1 |
11.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 1.1 |
3.2 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 1.1 |
3.2 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.0 |
9.4 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.0 |
11.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 1.0 |
3.1 |
GO:0045004 |
DNA replication proofreading(GO:0045004) |
| 1.0 |
6.2 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 1.0 |
3.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 1.0 |
3.1 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) |
| 1.0 |
2.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 1.0 |
3.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 1.0 |
9.2 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 1.0 |
10.2 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 1.0 |
3.0 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 1.0 |
7.1 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 1.0 |
10.1 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 1.0 |
10.1 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 1.0 |
1.0 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 1.0 |
3.0 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 1.0 |
8.9 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 1.0 |
3.0 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 1.0 |
2.9 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.0 |
14.7 |
GO:0048864 |
stem cell development(GO:0048864) |
| 1.0 |
5.9 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.0 |
1.0 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 1.0 |
12.7 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 1.0 |
3.9 |
GO:0000279 |
M phase(GO:0000279) |
| 1.0 |
2.9 |
GO:0043586 |
tongue development(GO:0043586) |
| 1.0 |
11.7 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 1.0 |
1.0 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 1.0 |
1.0 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 1.0 |
1.0 |
GO:0060319 |
primitive erythrocyte differentiation(GO:0060319) |
| 1.0 |
1.9 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 1.0 |
1.0 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 1.0 |
16.3 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 1.0 |
3.8 |
GO:0046655 |
glycine biosynthetic process(GO:0006545) folic acid metabolic process(GO:0046655) |
| 1.0 |
7.7 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.0 |
4.8 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 1.0 |
1.9 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.0 |
6.7 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.9 |
1.9 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.9 |
2.8 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.9 |
0.9 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.9 |
2.8 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.9 |
2.8 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.9 |
4.7 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.9 |
5.6 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.9 |
2.8 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.9 |
2.8 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.9 |
0.9 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.9 |
4.6 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.9 |
6.4 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.9 |
3.6 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.9 |
3.6 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.9 |
36.9 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.9 |
3.6 |
GO:1903286 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.9 |
2.7 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.9 |
2.6 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.9 |
5.3 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.9 |
7.0 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.9 |
3.5 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.9 |
6.1 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.9 |
3.5 |
GO:0072272 |
proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.9 |
2.6 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.9 |
0.9 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.9 |
1.7 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.9 |
1.7 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.8 |
2.5 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.8 |
2.5 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.8 |
3.4 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.8 |
6.7 |
GO:0043584 |
nose development(GO:0043584) |
| 0.8 |
2.5 |
GO:0035937 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.8 |
1.7 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.8 |
5.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.8 |
5.0 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.8 |
2.5 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.8 |
3.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.8 |
1.7 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.8 |
18.2 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.8 |
2.5 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.8 |
1.6 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.8 |
2.5 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.8 |
2.5 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.8 |
4.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.8 |
0.8 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.8 |
6.4 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.8 |
2.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.8 |
3.2 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.8 |
8.7 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.8 |
6.4 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.8 |
4.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.8 |
2.4 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.8 |
3.9 |
GO:0032962 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.8 |
0.8 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.8 |
7.0 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.8 |
0.8 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.8 |
2.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.8 |
3.1 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.8 |
10.0 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.8 |
0.8 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.8 |
22.1 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.8 |
1.5 |
GO:0072235 |
distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) |
| 0.8 |
1.5 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.8 |
0.8 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.8 |
3.0 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.8 |
1.5 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.8 |
19.6 |
GO:0006336 |
DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.8 |
3.8 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.7 |
6.0 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.7 |
3.7 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.7 |
0.7 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.7 |
8.9 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.7 |
11.8 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.7 |
4.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.7 |
1.5 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.7 |
1.5 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.7 |
0.7 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 0.7 |
0.7 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.7 |
4.3 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.7 |
1.4 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.7 |
1.4 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.7 |
15.0 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.7 |
13.6 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.7 |
1.4 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.7 |
5.6 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.7 |
1.4 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.7 |
4.9 |
GO:0021889 |
olfactory bulb interneuron differentiation(GO:0021889) |
| 0.7 |
7.0 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.7 |
0.7 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.7 |
6.9 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.7 |
3.5 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.7 |
5.5 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.7 |
4.1 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.7 |
2.1 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.7 |
2.1 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.7 |
1.4 |
GO:0010224 |
response to UV-B(GO:0010224) |
| 0.7 |
2.0 |
GO:0072217 |
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) negative regulation of metanephros development(GO:0072217) |
| 0.7 |
1.4 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.7 |
2.0 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.7 |
7.4 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.7 |
6.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.7 |
0.7 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.7 |
3.4 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.7 |
0.7 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.7 |
4.0 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.7 |
9.3 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.7 |
1.3 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.7 |
2.0 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.7 |
3.3 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.7 |
2.6 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.7 |
2.6 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.7 |
19.0 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.7 |
4.6 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.7 |
2.0 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.7 |
2.6 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.6 |
3.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.6 |
11.7 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.6 |
2.6 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.6 |
3.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.6 |
3.9 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.6 |
1.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.6 |
2.6 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.6 |
1.9 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.6 |
5.1 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.6 |
1.3 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.6 |
2.6 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.6 |
6.4 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.6 |
1.3 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.6 |
1.3 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.6 |
5.0 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.6 |
5.0 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.6 |
11.2 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.6 |
1.2 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.6 |
5.6 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.6 |
13.5 |
GO:0019076 |
viral release from host cell(GO:0019076) regulation of viral release from host cell(GO:1902186) |
| 0.6 |
2.5 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.6 |
3.7 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.6 |
9.1 |
GO:0045830 |
positive regulation of isotype switching(GO:0045830) |
| 0.6 |
1.8 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.6 |
2.4 |
GO:0044838 |
cell cycle phase(GO:0022403) cell quiescence(GO:0044838) |
| 0.6 |
1.2 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.6 |
1.2 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
| 0.6 |
0.6 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.6 |
6.6 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.6 |
1.8 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.6 |
3.6 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.6 |
4.8 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.6 |
4.2 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.6 |
0.6 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.6 |
1.8 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.6 |
0.6 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.6 |
1.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.6 |
0.6 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.6 |
4.1 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.6 |
2.3 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.6 |
0.6 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.6 |
0.6 |
GO:0061357 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.6 |
1.7 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.6 |
1.7 |
GO:0045819 |
plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.6 |
3.5 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.6 |
0.6 |
GO:1903760 |
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
| 0.6 |
0.6 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.6 |
3.4 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.6 |
1.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 |
0.6 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.6 |
0.6 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.6 |
0.6 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.6 |
0.6 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.6 |
6.1 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.6 |
1.1 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.6 |
0.6 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.6 |
3.9 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.6 |
0.6 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.5 |
3.8 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.5 |
1.6 |
GO:0098869 |
cellular oxidant detoxification(GO:0098869) |
| 0.5 |
0.5 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.5 |
3.3 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.5 |
1.1 |
GO:1904923 |
regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
| 0.5 |
1.6 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.5 |
0.5 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.5 |
1.6 |
GO:0032493 |
detection of bacterium(GO:0016045) response to bacterial lipoprotein(GO:0032493) detection of other organism(GO:0098543) |
| 0.5 |
1.6 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.5 |
3.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.5 |
1.1 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.5 |
19.3 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.5 |
0.5 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.5 |
2.7 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.5 |
8.5 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.5 |
1.1 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.5 |
1.6 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.5 |
3.7 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.5 |
1.6 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.5 |
0.5 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.5 |
2.1 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.5 |
0.5 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.5 |
1.5 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.5 |
3.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.5 |
1.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 |
6.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.5 |
1.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.5 |
2.0 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.5 |
1.5 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.5 |
1.5 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.5 |
2.0 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.5 |
3.0 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.5 |
2.0 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 |
1.0 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.5 |
1.0 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.5 |
4.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.5 |
0.5 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.5 |
1.0 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.5 |
2.0 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.5 |
2.9 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.5 |
1.0 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.5 |
1.5 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.5 |
1.0 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.5 |
1.5 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.5 |
1.5 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.5 |
1.9 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.5 |
3.9 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.5 |
0.5 |
GO:0042637 |
catagen(GO:0042637) |
| 0.5 |
1.4 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.5 |
0.5 |
GO:1903406 |
regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.5 |
1.9 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.5 |
1.9 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.5 |
0.9 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) negative regulation of t-circle formation(GO:1904430) |
| 0.5 |
0.5 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.5 |
0.9 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
| 0.5 |
0.5 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.5 |
17.4 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.5 |
3.7 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.5 |
0.9 |
GO:1900044 |
regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.5 |
1.4 |
GO:1903363 |
negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.5 |
7.0 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.5 |
0.9 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 |
34.3 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.5 |
1.4 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.5 |
3.2 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.5 |
0.5 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.5 |
1.8 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.5 |
3.7 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.5 |
3.6 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.5 |
3.2 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.5 |
1.8 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.5 |
3.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.5 |
8.1 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.5 |
4.5 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.5 |
0.9 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.4 |
0.9 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.4 |
1.8 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.4 |
0.9 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.4 |
1.3 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.4 |
0.9 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.4 |
2.2 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.4 |
1.3 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.4 |
1.3 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.4 |
2.2 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.4 |
0.9 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.4 |
2.1 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.4 |
3.8 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.4 |
3.0 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.4 |
3.0 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.4 |
4.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.4 |
1.7 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.4 |
0.8 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.4 |
2.9 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.4 |
5.0 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.4 |
1.3 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.4 |
0.8 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.4 |
1.7 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.4 |
3.7 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.4 |
0.4 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.4 |
1.7 |
GO:0003253 |
cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
| 0.4 |
1.6 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.4 |
2.9 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.4 |
4.5 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.4 |
2.4 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.4 |
3.2 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.4 |
4.4 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.4 |
3.6 |
GO:0099625 |
ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.4 |
0.4 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.4 |
0.4 |
GO:0044793 |
negative regulation by host of viral process(GO:0044793) |
| 0.4 |
1.6 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.4 |
3.6 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.4 |
0.4 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.4 |
3.6 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.4 |
0.8 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.4 |
3.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.4 |
2.0 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.4 |
0.8 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.4 |
0.8 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.4 |
1.2 |
GO:2000054 |
regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.4 |
0.8 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.4 |
1.6 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.4 |
2.7 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.4 |
0.4 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.4 |
0.8 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.4 |
2.7 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.4 |
1.2 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.4 |
0.8 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 |
1.1 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.4 |
0.4 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.4 |
1.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.4 |
0.8 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.4 |
1.1 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 0.4 |
6.8 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.4 |
0.7 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.4 |
2.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.4 |
4.5 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
| 0.4 |
4.1 |
GO:1901623 |
regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.4 |
2.2 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.4 |
1.8 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.4 |
5.9 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.4 |
0.7 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.4 |
1.5 |
GO:0060479 |
lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
| 0.4 |
1.1 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.4 |
3.3 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.4 |
4.7 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.4 |
1.5 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.4 |
1.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.4 |
1.1 |
GO:0021871 |
forebrain regionalization(GO:0021871) |
| 0.4 |
1.4 |
GO:0070922 |
small RNA loading onto RISC(GO:0070922) |
| 0.4 |
0.4 |
GO:1902170 |
cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
| 0.4 |
0.4 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.4 |
1.1 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.4 |
1.1 |
GO:1903430 |
oocyte maturation(GO:0001556) negative regulation of cell maturation(GO:1903430) |
| 0.4 |
1.8 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.4 |
4.9 |
GO:0051299 |
mitotic centrosome separation(GO:0007100) centrosome separation(GO:0051299) |
| 0.4 |
1.8 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.3 |
1.0 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.3 |
2.1 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.3 |
1.0 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.3 |
1.4 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.3 |
0.7 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.3 |
0.7 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.3 |
4.8 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.3 |
1.7 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.3 |
1.4 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 |
0.7 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 |
0.7 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.3 |
1.3 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.3 |
0.7 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.3 |
2.0 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
0.3 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 0.3 |
0.3 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.3 |
0.6 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.3 |
6.1 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.3 |
1.0 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.3 |
2.6 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 |
1.3 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 |
1.3 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.3 |
0.3 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
0.6 |
GO:0048048 |
embryonic eye morphogenesis(GO:0048048) |
| 0.3 |
1.0 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.3 |
1.9 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.3 |
7.7 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.3 |
3.2 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.3 |
2.2 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.3 |
3.1 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.3 |
3.8 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.3 |
3.7 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.3 |
2.2 |
GO:1902510 |
regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.3 |
0.9 |
GO:0019732 |
antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.3 |
1.6 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.3 |
0.3 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.3 |
1.6 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 |
0.6 |
GO:0072431 |
signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.3 |
0.9 |
GO:0072081 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.3 |
1.2 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.3 |
0.6 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.3 |
4.0 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.3 |
0.3 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.3 |
2.4 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.3 |
0.3 |
GO:1902730 |
positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.3 |
2.7 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.3 |
0.6 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 |
0.6 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.3 |
1.5 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.3 |
0.6 |
GO:1904683 |
regulation of metalloendopeptidase activity(GO:1904683) |
| 0.3 |
0.6 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.3 |
0.3 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 |
0.6 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.3 |
2.4 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.3 |
1.8 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 0.3 |
3.6 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.3 |
0.9 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) |
| 0.3 |
0.9 |
GO:2000105 |
positive regulation of DNA-dependent DNA replication(GO:2000105) |
| 0.3 |
0.6 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.3 |
3.0 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.3 |
2.7 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 |
0.3 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.3 |
0.3 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.3 |
0.6 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.3 |
1.5 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.3 |
0.6 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.3 |
1.2 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.3 |
0.9 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.3 |
1.2 |
GO:0044818 |
mitotic G2/M transition checkpoint(GO:0044818) |
| 0.3 |
2.6 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.3 |
0.3 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.3 |
0.9 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.3 |
0.9 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.3 |
0.3 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.3 |
0.6 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.3 |
1.4 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.3 |
0.9 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.3 |
1.1 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.3 |
1.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.3 |
0.6 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.3 |
1.1 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.3 |
4.2 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.3 |
0.6 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.3 |
2.5 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.3 |
2.8 |
GO:0048016 |
inositol phosphate-mediated signaling(GO:0048016) |
| 0.3 |
3.3 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 |
1.4 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.3 |
4.4 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.3 |
0.8 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.3 |
1.6 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.3 |
1.1 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.3 |
2.7 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.3 |
1.1 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.3 |
0.8 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.3 |
0.3 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.3 |
1.3 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.3 |
1.3 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 |
0.3 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.3 |
0.8 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.3 |
0.3 |
GO:0032056 |
positive regulation of translation in response to stress(GO:0032056) |
| 0.3 |
1.3 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.3 |
1.9 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 |
1.3 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.3 |
0.5 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.3 |
0.3 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.3 |
3.1 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 |
2.6 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.3 |
1.3 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.3 |
1.3 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.3 |
0.8 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 |
0.3 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.3 |
0.8 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.3 |
1.0 |
GO:0006309 |
DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.3 |
0.8 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.3 |
0.8 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.3 |
6.6 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.3 |
0.3 |
GO:1903960 |
negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
| 0.3 |
0.5 |
GO:0090325 |
regulation of locomotion involved in locomotory behavior(GO:0090325) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.3 |
2.5 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.3 |
0.8 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.3 |
1.0 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.3 |
4.8 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.3 |
0.5 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.2 |
0.7 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.2 |
0.7 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 |
0.2 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.2 |
4.7 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.2 |
2.5 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.2 |
0.2 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.2 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
3.7 |
GO:0032369 |
negative regulation of lipid transport(GO:0032369) |
| 0.2 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
2.4 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
0.7 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 |
1.0 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
1.0 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.2 |
1.5 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.2 |
0.5 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 |
0.2 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.2 |
3.4 |
GO:2000779 |
regulation of double-strand break repair(GO:2000779) |
| 0.2 |
0.7 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.2 |
1.0 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.2 |
1.2 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 |
1.7 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.2 |
0.5 |
GO:0014009 |
glial cell proliferation(GO:0014009) |
| 0.2 |
0.9 |
GO:0035561 |
regulation of chromatin binding(GO:0035561) |
| 0.2 |
0.2 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
0.7 |
GO:0070562 |
response to vitamin D(GO:0033280) regulation of vitamin D receptor signaling pathway(GO:0070562) cellular response to vitamin D(GO:0071305) |
| 0.2 |
2.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
0.5 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.2 |
1.6 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.2 |
1.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
0.7 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
1.2 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.2 |
1.6 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.2 |
0.7 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.2 |
2.5 |
GO:0007091 |
metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.2 |
0.9 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 |
1.4 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.2 |
0.7 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.2 |
0.4 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.2 |
0.7 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
1.6 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 |
0.7 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
0.7 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.2 |
0.4 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 |
1.1 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.2 |
0.4 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.2 |
0.2 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.2 |
0.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
0.6 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
0.2 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.2 |
0.2 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.2 |
4.1 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.2 |
0.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 |
3.0 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.2 |
1.3 |
GO:0043501 |
regulation of skeletal muscle adaptation(GO:0014733) skeletal muscle adaptation(GO:0043501) |
| 0.2 |
0.6 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 |
1.9 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.2 |
0.6 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
0.6 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
0.8 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 |
0.8 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
0.6 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.2 |
1.6 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
0.8 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 |
0.6 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.2 |
2.6 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.2 |
0.4 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.2 |
1.0 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.2 |
0.6 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.2 |
1.4 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.2 |
0.8 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.2 |
4.8 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.2 |
2.6 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.2 |
0.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.2 |
4.0 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 |
4.2 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.2 |
0.2 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.2 |
0.2 |
GO:0090190 |
positive regulation of mesonephros development(GO:0061213) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.2 |
1.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
0.6 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) neurotransmitter reuptake(GO:0098810) |
| 0.2 |
0.8 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.2 |
1.8 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
0.4 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.2 |
0.4 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
2.5 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.2 |
0.2 |
GO:0060964 |
regulation of gene silencing by miRNA(GO:0060964) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.2 |
8.5 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.2 |
1.9 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.2 |
1.5 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.2 |
0.4 |
GO:1900048 |
positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.2 |
1.7 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.2 |
0.9 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.2 |
2.0 |
GO:0014020 |
primary neural tube formation(GO:0014020) |
| 0.2 |
0.6 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.2 |
0.7 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
0.6 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
2.6 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.2 |
1.7 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.2 |
0.9 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 |
0.5 |
GO:0003348 |
cardiac endothelial cell differentiation(GO:0003348) |
| 0.2 |
2.6 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
0.5 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 |
0.7 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.2 |
1.1 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
1.4 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
0.2 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.2 |
4.8 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.2 |
1.2 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
1.2 |
GO:1902750 |
negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.2 |
1.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
0.5 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.2 |
0.7 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.2 |
0.5 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.2 |
0.9 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.2 |
0.7 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.3 |
GO:0060969 |
negative regulation of gene silencing(GO:0060969) |
| 0.2 |
0.3 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.2 |
1.2 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.2 |
0.3 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.2 |
1.4 |
GO:0035196 |
production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
| 0.2 |
1.7 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 |
0.9 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.2 |
0.7 |
GO:0046512 |
sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.2 |
0.3 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.2 |
4.1 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 |
0.8 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.2 |
3.7 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.2 |
0.8 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.2 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.2 |
0.5 |
GO:0090085 |
regulation of protein deubiquitination(GO:0090085) |
| 0.2 |
0.2 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.8 |
GO:0007320 |
insemination(GO:0007320) |
| 0.2 |
0.8 |
GO:0098706 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 |
0.3 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.2 |
0.3 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.2 |
3.4 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.2 |
1.0 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
0.2 |
GO:0086028 |
bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.2 |
0.7 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.2 |
0.5 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.2 |
0.7 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 |
0.6 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.2 |
0.3 |
GO:1904468 |
negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.2 |
0.8 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 |
0.2 |
GO:0042268 |
regulation of cytolysis(GO:0042268) negative regulation of cytolysis(GO:0045918) |
| 0.2 |
0.6 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 |
0.8 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.2 |
0.5 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.2 |
0.8 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.2 |
0.9 |
GO:0050688 |
regulation of defense response to virus(GO:0050688) |
| 0.2 |
1.7 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
| 0.2 |
0.5 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
0.5 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.8 |
GO:1903961 |
positive regulation of anion transmembrane transport(GO:1903961) |
| 0.2 |
0.3 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.1 |
0.4 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
6.6 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.3 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
0.4 |
GO:0021684 |
cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
2.0 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.1 |
5.8 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.1 |
0.6 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.3 |
GO:0072203 |
cell proliferation involved in metanephros development(GO:0072203) |
| 0.1 |
1.0 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
3.8 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
1.0 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.1 |
2.5 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.3 |
GO:1903273 |
regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
| 0.1 |
0.3 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 |
1.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.3 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.1 |
0.9 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.1 |
0.7 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
4.1 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.3 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.1 |
1.6 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 |
1.1 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.3 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.4 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
1.1 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.9 |
GO:0009437 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.1 |
3.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
1.0 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
1.3 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.3 |
GO:0072103 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.1 |
0.3 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
1.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
1.1 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
1.4 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.1 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.5 |
GO:0015793 |
renal water transport(GO:0003097) glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
| 0.1 |
0.9 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
0.2 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.5 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.1 |
1.1 |
GO:0006260 |
DNA replication(GO:0006260) |
| 0.1 |
0.5 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.6 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
| 0.1 |
1.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
0.1 |
GO:1905153 |
regulation of membrane invagination(GO:1905153) |
| 0.1 |
0.1 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.1 |
0.2 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.1 |
0.6 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
0.1 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.5 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.1 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.1 |
0.6 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.1 |
0.2 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.1 |
0.8 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.3 |
GO:0034473 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.1 |
0.3 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
2.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.1 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
1.6 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.6 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 |
0.2 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.1 |
0.3 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.2 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.1 |
0.3 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.1 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.1 |
0.7 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
0.6 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.1 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.3 |
GO:0033045 |
regulation of sister chromatid segregation(GO:0033045) |
| 0.1 |
1.7 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
1.6 |
GO:0006402 |
mRNA catabolic process(GO:0006402) |
| 0.1 |
2.2 |
GO:0035966 |
response to topologically incorrect protein(GO:0035966) |
| 0.1 |
0.8 |
GO:1904292 |
regulation of ERAD pathway(GO:1904292) |
| 0.1 |
0.5 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 |
0.5 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.5 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
1.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.6 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.1 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.1 |
0.5 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
2.6 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
2.0 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
0.4 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.5 |
GO:0051189 |
molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 |
1.6 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.3 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
| 0.1 |
0.1 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.5 |
GO:0032648 |
regulation of interferon-beta production(GO:0032648) |
| 0.1 |
0.6 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 |
6.4 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.1 |
3.6 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.3 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.3 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
0.1 |
GO:0010870 |
positive regulation of receptor biosynthetic process(GO:0010870) |
| 0.1 |
0.2 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.1 |
0.4 |
GO:0090559 |
regulation of membrane permeability(GO:0090559) |
| 0.1 |
0.6 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 |
0.5 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 |
0.3 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.1 |
0.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.3 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.2 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.1 |
0.2 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.6 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
1.0 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
2.4 |
GO:0007179 |
transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.1 |
0.3 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.1 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.3 |
GO:0042119 |
neutrophil activation(GO:0042119) |
| 0.1 |
0.3 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.3 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
1.5 |
GO:0031960 |
response to corticosteroid(GO:0031960) response to glucocorticoid(GO:0051384) |
| 0.1 |
1.1 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.8 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.6 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.9 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.5 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.1 |
0.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.2 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.1 |
0.2 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.1 |
0.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
0.3 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.1 |
0.6 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.1 |
0.4 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.1 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 0.1 |
0.1 |
GO:2000851 |
cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.1 |
0.2 |
GO:0002070 |
epithelial cell maturation(GO:0002070) |
| 0.1 |
0.2 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.1 |
0.4 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.1 |
0.4 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.1 |
GO:1900121 |
regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.1 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.1 |
0.4 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.4 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.1 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
2.2 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 0.1 |
0.1 |
GO:0072172 |
ureteric bud formation(GO:0060676) mesonephric tubule formation(GO:0072172) |
| 0.1 |
3.1 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.3 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
0.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.2 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 |
1.1 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 |
0.2 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.4 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
3.4 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.2 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 |
0.1 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
0.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.5 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
0.2 |
GO:0031063 |
regulation of histone deacetylation(GO:0031063) |
| 0.1 |
0.1 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.1 |
0.2 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 |
0.1 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.4 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
0.5 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.1 |
0.1 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.1 |
0.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
0.1 |
GO:0046131 |
pyrimidine ribonucleoside metabolic process(GO:0046131) |
| 0.1 |
2.0 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
0.1 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.2 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.2 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 |
0.7 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.1 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.1 |
0.4 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.4 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.1 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.2 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
0.4 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.4 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 |
0.2 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.6 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
3.3 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.1 |
0.6 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.1 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.6 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.0 |
0.8 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.1 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.0 |
0.1 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
0.2 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.2 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 |
0.2 |
GO:1902745 |
positive regulation of lamellipodium organization(GO:1902745) |
| 0.0 |
0.4 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.1 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.1 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.0 |
0.0 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.0 |
1.2 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.5 |
GO:0000086 |
G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 |
0.3 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.0 |
1.0 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.0 |
0.2 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.2 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.4 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.0 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.0 |
0.1 |
GO:0031646 |
positive regulation of neurological system process(GO:0031646) |
| 0.0 |
0.1 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.3 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 |
0.7 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.2 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.0 |
0.1 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.0 |
0.1 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
0.0 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 |
0.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 |
0.1 |
GO:0071549 |
cellular response to dexamethasone stimulus(GO:0071549) |
| 0.0 |
0.8 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.0 |
0.0 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.0 |
0.1 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.0 |
0.0 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.1 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.0 |
0.2 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.0 |
0.1 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.0 |
0.4 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.1 |
GO:2000641 |
regulation of early endosome to late endosome transport(GO:2000641) |
| 0.0 |
0.8 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.2 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.2 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.0 |
0.3 |
GO:0060324 |
face development(GO:0060324) |
| 0.0 |
0.0 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.0 |
0.0 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
1.0 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.1 |
GO:0035826 |
rubidium ion transport(GO:0035826) |
| 0.0 |
0.1 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.0 |
0.0 |
GO:0007006 |
mitochondrial membrane organization(GO:0007006) |
| 0.0 |
0.1 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.0 |
0.1 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.0 |
0.0 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.3 |
GO:0001738 |
morphogenesis of a polarized epithelium(GO:0001738) |
| 0.0 |
0.2 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
0.5 |
GO:0006754 |
ATP biosynthetic process(GO:0006754) |
| 0.0 |
0.2 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.0 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.0 |
0.0 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.0 |
0.1 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.1 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.0 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.0 |
0.1 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.0 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.0 |
0.3 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
